Teladoc Health Inc at Piper Sandler Healthcare Conference Transcript

Nov 30, 2022 / 08:00PM GMT
Jessica Elizabeth Tassan - Piper Sandler & Co., Research Division - VP & Senior Research Analyst

My name is Jess Tassan. I am -- I cover health care tech and distribution at Piper. I'm thrilled to have with me here today Jason Gorevic, CEO of Teladoc; and Mala Murthy, CFO of Teladoc. Thank you both very much for joining.

Jason Nathanial Gorevic - Teladoc Health, Inc. - CEO & Director

Thanks for having us.

Questions and Answers:

Jessica Elizabeth Tassan - Piper Sandler & Co., Research Division - VP & Senior Research Analyst

All right. Great. So we've got 25 minutes for Q&A. I won't direct the questions. You guys can decide where each is best suited. So our overweight thesis on Teladoc is based on your back scale, the integrity of the brand and the potential to drive incremental monetization of each life on the platform. Can you just remind us roughly how many lives touches in 2022 across each product line or maybe in aggregate?

Jason Nathanial Gorevic -
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot